Robert Lorne Hopfner - Director, 10%+ Owner at Evommune, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Issuer Symbol
EVMN on NYSE
All Insider Reports
All Insider Reports

Robert Lorne Hopfner - trading volume in the past year for Evommune, Inc.

Holdings reported by Robert Lorne Hopfner for Evommune, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,632,441 $30,608,268 $18.75 19 Dec 2025 By Pivotal bioVenture Partners Fund I, L.P.
Common Stock 1,441,032 $27,019,350 $18.75 19 Dec 2025 By NFLS Delta III Limited
Common Stock 294,502 $5,521,912 $18.75 19 Dec 2025 By Pivotal bioVenture Partners Fund II, L.P.
Common Stock 4,026 $69,851 $17.35 19 Dec 2025 By Trust
Series A Preferred Stock 0 07 Nov 2025 By NFLS Delta III Limited Common Stock
Series A Preferred Stock 0 07 Nov 2025 By Pivotal bioVenture Partners Fund I, L.P. Common Stock
Series B Preferred Stock 0 07 Nov 2025 By NFLS Delta III Limited Common Stock
Series B Preferred Stock 0 07 Nov 2025 By Pivotal bioVenture Partners Fund I, L.P. Common Stock
Series C Preferred Stock 0 07 Nov 2025 By NFLS Delta III Limited Common Stock
Series C Preferred Stock 0 07 Nov 2025 By Pivotal bioVenture Partners Fund II, L.P. Common Stock
Series C Preferred Stock 0 07 Nov 2025 By Pivotal bioVenture Partners Fund I, L.P. Common Stock
Series Seed Preferred Stock 0 07 Nov 2025 By NFLS Delta III Limited Common Stock
Series Seed Preferred Stock 0 07 Nov 2025 By Pivotal bioVenture Partners Fund I, L.P. Common Stock
Series Seed Preferred Stock 0 07 Nov 2025 By Trust Common Stock

Transactions reported by Robert Lorne Hopfner for Evommune, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.